BMI

Conclusions

• 🟢Price vs. SMA 50 — Price is above the 50-day average
• 🔴Price vs. SMA 200 — Price is below the 200-day average
• 🟢MACD — MACD histogram is positive — rising momentum
• 🟢RSI — RSI 54.1 — healthy positive momentum
• 🟡Stochastic — %K 66.3 — neutral range
• 🟡ADX (trend strength) — ADX 13.7 — weak trend/choppy
• 🔴Volume trend — Volume is falling despite the price advance — possible weakening
• 🟢Relative strength vs. S&P 500 — +8.9% over the last 3 months relative to the index
• 🔴ROC (rate of change) — ROC 12 days: -3.6%
• 🔴Parabolic SAR — Price is below the SAR point — downtrend
• 🟡CMF (money flow) — CMF 20 days: -0.03

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = resistance plusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Profit Targets by Risk/Reward Ratio (R)

Conclusions

• 🟢Gross margin — Gross margin: 41.7% — strong
• 🟢Operating margin — Operating margin: 20.0% — strong
• 🟢Net margin — Net margin: 15.5% — strong
• 🟡Return on equity (ROE) — Return on equity (ROE): 19.9% — reasonable
• 🟢Return on assets (ROA) — Return on assets (ROA): 14.5% — strong
• 🟢Current ratio (liquidity) — Current ratio: 3.36
• 🟢Debt-to-equity — Debt/equity: 0.00

Conclusions

• 🟢Revenue growth (last year) — Revenue growth (last year): 10.9%
• 🟢Earnings per share (EPS) growth — Earnings per share (EPS) growth: 13.2%
• 🟢Free cash flow growth — Free cash flow growth: 19.3%
• 🟢Net income growth — Net income growth: 13.4%

Conclusions

• 🟡DCF Fair Value — Estimated fair value: $125.89 vs. price $137.17 (-8.2%)
• 🟡Tangible Net Asset Value (NAV) — NAV per share: $12.15
• 🟡P/E — P/E: 29.3